Go Pro
→ These gold assets are priced for $1,800 gold [it's over $4,000] (From Golden Portfolio) (Ad)tc pixel Free RYTM Stock Alerts

Rhythm Pharmaceuticals (RYTM) News Today

Rhythm Pharmaceuticals logo
$111.61 +1.61 (+1.46%)
As of 02:56 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Rhythm Pharmaceuticals Latest News

Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan
August 24 at 8:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/24/3349657/0/en/rhythm-pharmaceuticals-announces-mhlw-approval-of-imcivree-setmelanotide-for-patients-with-acquired-hypothalamic-obesity-ho-in-japan.html
6,156,902 Shares in Rhythm Pharmaceuticals, Inc. $RYTM Purchased by BlackRock Inc.
August 24 at 3:35 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-6156902-shares-in-rhythm-pharmaceuticals-inc-rytm-purchased-by-blackrock-inc-2026-08-24/
Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can
August 23 at 6:00 PM  |  fool.comhttps://www.fool.com/investing/2026/08/23/eli-lilly-and-novo-nordisk-cant-treat-this-form-of/
Deutsche Bank AG Purchases New Position in Rhythm Pharmaceuticals, Inc. $RYTM
August 23 at 3:43 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-deutsche-bank-ag-purchases-new-position-in-rhythm-pharmaceuticals-inc-rytm-2026-08-23/
Blue Owl Capital Holdings LP Invests $6.82 Million in Rhythm Pharmaceuticals, Inc. $RYTM
August 21 at 3:35 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-blue-owl-capital-holdings-lp-invests-682-million-in-rhythm-pharmaceuticals-inc-rytm-2026-08-21/
Rhythm Pharmaceuticals: Building A Defensive MC4R Franchise
August 18, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4937599-rhythm-pharmaceuticals-building-a-defensive-mc4r-franchise
Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Joseph Shulman Sells 5,079 Shares
August 18, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-rytm-insider-buying-and-selling-2026-08-18/
Insider Selling: Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Sells 5,079 Shares of Stock
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-selling-rhythm-pharmaceuticals-nasdaqrytm-insider-sells-5079-shares-of-stock-2026-08-17/
Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Alastair Garfield Sells 7,763 Shares
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/rhythm-pharmaceuticals-nasdaqrytm-insider-alastair-garfield-sells-7763-shares-2026-08-17/
Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer
August 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/17/3346041/0/en/rhythm-pharmaceuticals-announces-appointment-of-manher-aj-joshi-as-chief-medical-officer.html
Rhythm Pharmaceuticals Eyes AHO Growth, Global IMCIVREE Expansion and Pipeline Catalysts
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/rhythm-pharmaceuticals-eyes-aho-growth-global-imcivree-expansion-and-pipeline-catalysts-2026-08-17/
Jennifer Kayden Lee Sells 75,834 Shares of Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock
August 16, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30964891
Yann Mazabraud Sells 57,000 Shares of Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock
August 16, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30964751
Rhythm Pharmaceuticals (NASDAQ:RYTM) EVP Yann Mazabraud Sells 57,000 Shares of Stock
August 15, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-rytm-insider-buying-and-selling-2026-08-15/
Rhythm Pharmaceuticals (NASDAQ:RYTM) EVP Yann Mazabraud Sells 57,000 Shares
August 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/rhythm-pharmaceuticals-nasdaqrytm-evp-yann-mazabraud-sells-57000-shares-2026-08-14/
Insider Selling: Rhythm Pharmaceuticals (NASDAQ:RYTM) EVP Sells 75,834 Shares of Stock
August 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-selling-rhythm-pharmaceuticals-nasdaqrytm-evp-sells-75834-shares-of-stock-2026-08-14/
Dimensional Fund Advisors LP Sells 12,867 Shares of Rhythm Pharmaceuticals, Inc. $RYTM
August 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-dimensional-fund-advisors-lp-sells-12867-shares-of-rhythm-pharmaceuticals-inc-rytm-2026-08-14/
Why Is Rhythm Pharmaceuticals Stock Trading Higher On Wednesday?
August 12, 2026  |  benzinga.comhttps://www.benzinga.com/markets/biotech/26/08/61152014/why-is-rhythm-pharmaceuticals-stock-trading-higher-on-wednesday?utm_source=snapi
Bank of America Corp DE Grows Stake in Rhythm Pharmaceuticals, Inc. $RYTM
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-america-corp-de-grows-stake-in-rhythm-pharmaceuticals-inc-rytm-2026-08-12/
Rhythm Pharmaceuticals (RYTM) Q2 2026 Earnings Call Transcript
August 11, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/rhythm-pharmaceuticals-rytm-q2-2026-164458580.html
Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in ...
August 11, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/rhythm-pharmaceuticals-announces-imcivree-setmelanotide-receives-expanded-marketing-authorization-in-the-united-kingdom-for-treatment-of-obesity-and-control-of-hunger-in-patients-with-acquired-1036440672
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Consensus Recommendation of "Moderate Buy" by Brokerages
August 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/rhythm-pharmaceuticals-inc-nasdaqrytm-given-consensus-recommendation-of-moderate-buy-by-brokerages-2026-08-11/
Assenagon Asset Management S.A. Invests $20.71 Million in Rhythm Pharmaceuticals, Inc. $RYTM
August 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-assenagon-asset-management-sa-invests-2071-million-in-rhythm-pharmaceuticals-inc-rytm-2026-08-10/
Citi Remains a Buy on Rhythm Pharmaceuticals (RYTM)
August 8, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/RYTM-Q/pressreleases/3687422/citi-remains-a-buy-on-rhythm-pharmaceuticals-rytm/
Rhythm Pharmaceuticals (NASDAQ:RYTM) Given New $146.00 Price Target at JPMorgan Chase & Co.
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/rhythm-pharmaceuticals-nasdaqrytm-given-new-14600-price-target-at-jpmorgan-chase-co-2026-08-07/
California State Teachers Retirement System Acquires 12,269 Shares of Rhythm Pharmaceuticals, Inc. $RYTM
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-california-state-teachers-retirement-system-acquires-12269-shares-of-rhythm-pharmaceuticals-inc-rytm-2026-08-07/
Analysts Offer Insights on Healthcare Companies: Moleculin Biotech (MBRX), Addus Homecare (ADUS) and Rhythm Pharmaceuticals (RYTM)
August 6, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/MBRX-Q/pressreleases/3683396/analysts-offer-insights-on-healthcare-companies-moleculin-biotech-mbrx-addus-homecare-adus-and-rhythm-pharmaceuticals-rytm/
Rhythm Pharmaceuticals Reports Promising Phase 2 Obesity Data
August 6, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/RYTM-Q/pressreleases/3662610/rhythm-pharmaceuticals-reports-promising-phase-2-obesity-data/
Citigroup Issues Positive Forecast for Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/citigroup-issues-positive-forecast-for-rhythm-pharmaceuticals-nasdaqrytm-stock-price-2026-08-05/
Royal Bank Of Canada Issues Positive Forecast for Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/royal-bank-of-canada-issues-positive-forecast-for-rhythm-pharmaceuticals-nasdaqrytm-stock-price-2026-08-05/
Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $160.00
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/rhythm-pharmaceuticals-nasdaqrytm-price-target-raised-to-16000-2026-08-05/
Rhythm Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
August 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4930761-rhythm-pharmaceuticals-inc-2026-q2-results-earnings-call-presentation
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
August 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/04/3338772/0/en/rhythm-pharmaceuticals-announces-participation-in-upcoming-investor-conferences.html
Rhythm Pharmaceuticals Q2 Earnings Call Highlights
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/rhythm-pharmaceuticals-q2-earnings-call-highlights-2026-08-04/
Full Transcript: Rhythm Pharmaceuticals Q2 2026 Earnings Call
August 4, 2026  |  benzinga.comhttps://www.benzinga.com/news/26/08/60907104/full-transcript-rhythm-pharmaceuticals-q2-2026-earnings-call
Rhythm Pharmaceuticals (NASDAQ:RYTM) Issues Quarterly Earnings Results
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/rhythm-pharmaceuticals-nasdaqrytm-issues-quarterly-earnings-results-2026-08-04/
Rhythm Pharma's obesity drug shows promise for brain tumor-related weight condition
August 4, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/rhythm-pharmas-obesity-drug-shows-promise-brain-tumor-related-weight-condition-2026-08-04/
Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
August 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/04/3338168/0/en/rhythm-pharmaceuticals-reports-second-quarter-2026-financial-results-and-business-update.html
Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity
August 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/04/3338126/0/en/rhythm-pharmaceuticals-announces-preliminary-data-from-phase-2-trial-that-showed-rm-718-demonstrated-positive-efficacy-signal-in-acquired-hypothalamic-obesity.html
Perceptive Advisors LLC Has $206.45 Million Stock Position in Rhythm Pharmaceuticals, Inc. $RYTM
August 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-perceptive-advisors-llc-has-20645-million-stock-position-in-rhythm-pharmaceuticals-inc-rytm-2026-08-02/
Rhythm Pharmaceuticals, Inc. $RYTM Shares Sold by Janus Henderson Group PLC
August 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-rhythm-pharmaceuticals-inc-rytm-shares-sold-by-janus-henderson-group-plc-2026-08-01/
Rhythm Pharmaceuticals Inc.
July 30, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/rytm/financials/cash-flow
Renaissance Technologies LLC Lowers Stake in Rhythm Pharmaceuticals, Inc. $RYTM
July 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-renaissance-technologies-llc-lowers-stake-in-rhythm-pharmaceuticals-inc-rytm-2026-07-30/
Rhythm Pharmaceuticals, Inc. $RYTM Position Raised by ADAR1 Capital Management LLC
July 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-rhythm-pharmaceuticals-inc-rytm-position-raised-by-adar1-capital-management-llc-2026-07-29/
Could Anticipated Q2 Earnings Beat Amid Weaker Profitability Reframe Rhythm Pharmaceuticals’ Growth Story (RYTM)?
July 28, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/could-anticipated-q2-earnings-beat-180757487.html
Rhythm Pharmaceuticals (RYTM) Projected to Announce Earnings on Tuesday
July 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/rhythm-pharmaceuticals-rytm-projected-to-announce-earnings-on-tuesday-2026-07-28/
Exome Asset Management LLC Takes $3.53 Million Position in Rhythm Pharmaceuticals, Inc. $RYTM
July 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-exome-asset-management-llc-takes-353-million-position-in-rhythm-pharmaceuticals-inc-rytm-2026-07-28/
Hsbc Holdings PLC Invests $1.23 Million in Rhythm Pharmaceuticals, Inc. $RYTM
July 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-hsbc-holdings-plc-invests-123-million-in-rhythm-pharmaceuticals-inc-rytm-2026-07-28/
Castleark Management LLC Sells 12,200 Shares of Rhythm Pharmaceuticals, Inc. $RYTM
July 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-castleark-management-llc-sells-12200-shares-of-rhythm-pharmaceuticals-inc-rytm-2026-07-28/
Rhythm Pharmaceuticals (NASDAQ:RYTM) Coverage Initiated by Analysts at JPMorgan Chase & Co.
July 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/rhythm-pharmaceuticals-nasdaqrytm-coverage-initiated-by-analysts-at-jpmorgan-chase-co-2026-07-27/

Rhythm Pharmaceuticals Media Mentions By Week

Rhythm Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RYTM
News Sentiment
▼
0.55

0.66
▲
Average
Healthcare
News Sentiment

Rhythm Pharmaceuticals News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RYTM Articles
This Week
▼
10

6
▲
RYTM Articles
Average Week

Rhythm Pharmaceuticals Trends on MarketBeat

This week vs. last week
Searches
2
+100%
Page Views
2,136
-2%
Get Rhythm Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RYTM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
News and Trends Tools

MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Rhythm Pharmaceuticals dated 8/24/2026.
From Our Partners
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
Someone just dumped the biggest gold fund.
Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...
Behind the Markets | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
A $382 trillion migration and the position no one is talking about
Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...
Awesomely | Sponsoredtc pixel
"Second Wave” Hitting Iran Soon? Wall Street Issues Warning
Analysts at Goldman Sachs and Morgan Stanley are warning that a quiet domestic threat - unrelated to overseas ...
TradeSmith | Sponsoredtc pixel
Free Stock Pick: The Company First in Line for America’s New Super Fuel
The U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by Pre...
Banyan Hill Publishing | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel